Researchers evaluated the comparative safety of Janus kinase inhibitors vs tumor necrosis factor inhibitors in older adults ...
Survey data show that most academic rheumatologists prescribe opioids for pain management and frequently experience patient ...
Vitamin K helps blood clot. Babies are born with very little of it, and breast milk supplies only small amounts, the US Centers for Disease Control and Prevention (CDC) explains. Without enough, a ...
A systematic review evaluates tapering and withdrawal strategies for IL-1 and IL-6 inhibitors in systemic juvenile idiopathic arthritis.
Medicare Part D data presented at ACR Convergence 2026 show a significant reversal in JAK inhibitor prescription growth following the 2021 FDA boxed warning.
Opioid therapy for pain management in idiopathic inflammatory myopathies carries a greater risk for respiratory failure than ...
Following clinical trial meta-analyses and real-world observational data, the FDA is requiring manufacturers of all GLP-1 receptor agonists to add warnings regarding nonarteritic anterior ischemic ...
Real-world data show baricitinib carries a higher pneumonia risk in patients with rheumatoid arthritis compared with other JAK inhibitors.
Tocilizumab was associated with lower 5-year mortality and reduced respiratory failure vs nintedanib in SSc-ILD in a TriNetX ...
Demographic factors and baseline characteristics have the greatest association with treatment persistence and response among ...
Patients with primary Sjögren disease and low vitamin A levels demonstrate a higher frequency of ocular surface damage ...
A celebrity's recent multiple sclerosis misdiagnosis highlights the complexities of medical liability and the error in judgment defense.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results